dioxadet has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleksandrov, VA; Aristova, VA; Beliaev, AM; Beliaeva, OA; Bespalov, VG; Ivantsov, AO; Kireeva, GS; Maĭdin, MA; Semënov, AL; Senchik, KIu; Stukov, AN; Vyshinskaia, EA | 1 |
| Aleksandrov, VA; Aristova, VA; Beliaev, AM; Beliaeva, OA; Bespalov, VG; Kireeva, GS; Kon'kov, SA; Krylova, IA; Maĭdin, MA; Semënov, AL; Senchik, KIu; Stukov, AN; Vyshinskaia, EA | 1 |
2 other study(ies) available for dioxadet and Experimental Neoplasms
| Article | Year |
|---|---|
[Experimental technology of chemoperfusion treatment for abdominal carcinomatosis in ovarian cancer].
Topics: Abdominal Neoplasms; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Female; Hyperthermia, Induced; Neoplasms, Experimental; Ovarian Neoplasms; Pelvis; Rats; Rats, Wistar; Triazines | 2014 |
[Antitumor effect of dioxadet in intraperitoneal chemoperfusion treatment for advanced ovarian cancer in experimental setting].
Topics: Animals; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Female; Hyperthermia, Induced; Infusions, Parenteral; Neoplasms, Experimental; Ovarian Neoplasms; Rats; Rats, Wistar; Survival Analysis; Treatment Outcome; Triazines | 2014 |